Riskpilot← Back to searchSign inGet full accessWendel Medical AB
ABActiveOrg 5568994650Sturevägen 43Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 20120 employees
Revenue 2025
SEK 0
EBITDA margin
—
+32% vs 2024
Equity ratio
99.1%
Financial strength
Net profit 2025
SEK -4K
+37% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -4K | +32% |
| Net profit | SEK -4K | +37% |
| Total assets | SEK 272K | -1% |
| Equity | SEK 270K | -1% |
| Employees | 0 | — |
Legal name
Wendel Medical AB
Org number
5568994650
Legal form
Aktiebolag
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
23 juli 2012
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Företaget ska bedriva konsultverksamhet företrädesvis inom medicin, management och IT, samt utveckla mjukvaruprodukter, äga och förvalta värdepapper, företag och fastigheter, samt utöva därmed förenlig verksamhet.
Address
Sturevägen 43
Email
carl.wendel@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 8 | 0 | 0 | 0 |
| Staff expenses | — | −0 | −0 | −0 | −0 |
| EBITDA | −30 | −15 | −14 | −6 | −4 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −30 | −15 | −14 | −6 | −4 |
| Net financials | 1 | — | 0 | — | 0 |
| Profit before tax | 1 | 0 | 0 | −6 | −4 |
| Tax | −1 | −0 | −0 | — | — |
| Net profit | 0 | 0 | −0 | −6 | −4 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 332 | 317 | 303 | 276 | 272 |
| Equity | 279 | 279 | 279 | 274 | 270 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 21 | 21 | 21 | 0 | — |
| Total debt | 21 | 21 | 21 | — | — |
EBITDA margin
-394800.0%
This company
15.8%
Market median
-2498834% vs market
20212025
Equity ratio
99.1%
This company
38.2%
Market median
+159% vs market
20212025
Return on equity
-1.4%
This company
18.4%
Market median
-108% vs market
20212025
Net profit margin
-367800.0%
This company
8.1%
Market median
-4540841% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wendel Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Fredrik Björn Wendel | Chairman | 0 companies |
| Sophia Carin Christina Wendel | Board of Directors | 0 companies |
| Erik Gustav Björn Wendel | Deputy Board Member | 0 companies |